Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevention and treatment of pneumocystis pneumonia.

× No keyword cloud information.

38 in total

Review 1. Update on the diagnosis and treatment of Pneumocystis pneumonia.

Authors: Eva M Carmona; Andrew H Limper
Journal: Ther Adv Respir Dis Date: 2010-08-24 Impact factor: 4.031

2. Indirect muscarinic receptor activation by pentamidine on airway smooth muscle.

Authors: K Biyah; M Molimard; E Naline; B Bazelly; C Advenier
Journal: Br J Pharmacol Date: 1996-11 Impact factor: 8.739

3. Detection of Pneumocystis carinii DNA in air samples: likely environmental risk to susceptible persons.

Authors: M S Bartlett; S H Vermund; R Jacobs; P J Durant; M M Shaw; J W Smith; X Tang; J J Lu; B Li; S Jin; C H Lee
Journal: J Clin Microbiol Date: 1997-10 Impact factor: 5.948

4. Trophozoite elimination in a rat model of Pneumocystis carinii pneumonia by clinically achievable plasma deferoxamine concentrations.

Authors: S Merali; K Chin; R W Grady; A B Clarkson
Journal: Antimicrob Agents Chemother Date: 1996-05 Impact factor: 5.191

5. Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide.

Authors: Stuart A Grossman; Xiaobu Ye; Glenn Lesser; Andrew Sloan; Hetty Carraway; Serena Desideri; Steven Piantadosi
Journal: Clin Cancer Res Date: 2011-07-07 Impact factor: 12.531

6. Guanylhydrazones in therapy of Pneumocystis carinii pneumonia in immunosuppressed rats.

Authors: P D Walzer; J Foy; J Runck; P Steele; M White; R S Klein; B A Otter; R J Sundberg
Journal: Antimicrob Agents Chemother Date: 1994-11 Impact factor: 5.191

Review 7. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.

Authors: Martin Rodriguez; Jay A Fishman
Journal: Clin Microbiol Rev Date: 2004-10 Impact factor: 26.132

8. Use of semiquantitative PCR to assess onset and treatment of Pneumocystis carinii infection in rat model.

Authors: T J O'Leary; M M Tsai; C F Wright; M T Cushion
Journal: J Clin Microbiol Date: 1995-03 Impact factor: 5.948

9. Pneumocystis pneumonia in brain tumor patients: risk factors and clinical features.

Authors: D Schiff
Journal: J Neurooncol Date: 1996-03 Impact factor: 4.130

10. Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis.

Authors: P D Walzer; J Foy; P Steele; M White
Journal: Antimicrob Agents Chemother Date: 1993-07 Impact factor: 5.191